Sanofi reportedly weighs Insmed takeover
Sanofi is considering acquiring U.S. drugmaker Insmed, a potential transaction that could rank among the largest biopharmaceutical deals in recent years. Bloomberg reported that Sanofi is consulting advisers, but discussions are ongoing, a deal could be weeks away, and an agreement is not guaranteed; other bidders could emerge. Insmed shares rose more than 6% after the report, while no purchase price or other deal terms were disclosed.



